This mechanism may provide a viable and specific method for controlling CD1a expression in the treatment of certain autoimmune diseases, and at the same time, it can also avoid transplant immune rejection and tumor immune evasion caused by abnormal expression of CD1a. This evidence concerns the gene CD1A and autoimmune disease.